Serum nitric oxide levels and flow-mediated dilatation in patients with Sheehan syndrome and the effect of combination therapy consisting of L-thyroxine, prednisolone, and conjugated estrogen/medroxyprogesterone acetate
dc.authorid | Akay, Hatice/0000-0002-0854-0904 | |
dc.contributor.author | Bahceci, Mithat | |
dc.contributor.author | Pasa, Semir | |
dc.contributor.author | Akay, Hatice O. | |
dc.contributor.author | Tuzcu, Alpaslan | |
dc.contributor.author | Tumer, Cemil | |
dc.contributor.author | Gokalp, Deniz | |
dc.date.accessioned | 2024-09-18T21:03:05Z | |
dc.date.available | 2024-09-18T21:03:05Z | |
dc.date.issued | 2008 | |
dc.department | Hatay Mustafa Kemal Üniversitesi | en_US |
dc.description.abstract | Baseline and stimulated nitric oxide (NO) levels were higher, whereas baseline arterial diameter, FMD-stimulated NO increment, and arterial dilatation ratio were lower in Sheehan syndrome (SS) patients than in control subjects. After combination therapy consisting of prednisolone, L-thyroxine, and conjugated estrogen, baseline and stimulated NO levels of SS remained as high, but FMID-stimulated NO, NO increment ratio, and arterial dilatation ratio increased with treatment. (Fertil Steril (R) 2008;89:995-7. (c) 2008 by American Society for Reproductive Medicine.) | en_US |
dc.identifier.doi | 10.1016/j.fertnstert.2007.04.014 | |
dc.identifier.endpage | 997 | en_US |
dc.identifier.issn | 0015-0282 | |
dc.identifier.issn | 1556-5653 | |
dc.identifier.issue | 4 | en_US |
dc.identifier.pmid | 17582407 | en_US |
dc.identifier.scopus | 2-s2.0-41749123745 | en_US |
dc.identifier.scopusquality | Q1 | en_US |
dc.identifier.startpage | 995 | en_US |
dc.identifier.uri | https://doi.org/10.1016/j.fertnstert.2007.04.014 | |
dc.identifier.uri | https://hdl.handle.net/20.500.12483/13241 | |
dc.identifier.volume | 89 | en_US |
dc.identifier.wos | WOS:000255250100036 | en_US |
dc.identifier.wosquality | Q1 | en_US |
dc.indekslendigikaynak | Web of Science | en_US |
dc.indekslendigikaynak | Scopus | en_US |
dc.indekslendigikaynak | PubMed | en_US |
dc.language.iso | en | en_US |
dc.publisher | Elsevier Science Inc | en_US |
dc.relation.ispartof | Fertility and Sterility | en_US |
dc.relation.publicationcategory | Diğer | en_US |
dc.rights | info:eu-repo/semantics/openAccess | en_US |
dc.subject | L-Arginine | en_US |
dc.subject | Synthase | en_US |
dc.subject | Replacement | en_US |
dc.subject | Necrosis | en_US |
dc.title | Serum nitric oxide levels and flow-mediated dilatation in patients with Sheehan syndrome and the effect of combination therapy consisting of L-thyroxine, prednisolone, and conjugated estrogen/medroxyprogesterone acetate | en_US |
dc.type | Editorial Material | en_US |
Dosyalar
Orijinal paket
1 - 1 / 1